gracecast151_lung_dr. kratz on prognosis of early lung cancer - part 2
Published 11 years ago • 56 plays • Length 11:35Download video MP4
Download video MP3
Similar videos
-
12:37
dr. kratz on prognosis of early lung cancer - part 1
-
3:03
stereotactic body radiation therapy (sbrt) for medically inoperable early stage lung cancer
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
0:09
lung cancer awareness month - #shorts #youtubeshorts
-
19:30
gracecast152_lung_dr. kratz_pt3_evidence for biology based staging
-
5:11
gracecastuc-015_lung_what is the biology of a mixed response in lung cancer?
-
6:56
gracecast - leading treatment options for patients with negative tumor pd-l1 nsclc with dr. stephen
-
8:03
gracecast - immunotherapy for small cell lung cancer with dr. stephen liu
-
17:36
gracecast-096_lung-cancer_mm in lc pt 1: dr. charles rudin on the lung cancer mutation consortium
-
6:00
perioperative keytruda for early stage nsclc-leading developments & current questions in lung cancer
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
2:00
keynote 671: perioperative pembrolizumab for nsclc - onctalk lung 2023
-
10:10
gracecast-017_lung-cancer_never-smokers with lung cancer
-
9:30
gracecast-037_lung-cancer_horton interview 1 - nsclc subtypes
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
5:09
gracecastuc-013_lung_what should we do for a "mixed response" to lung cancer treatment?
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc